NPORT-EX 2 JPMUSVAL.htm PART F EDGAR HTML
JPMorgan U.S. Value Fund
Schedule of Portfolio Investments as of March 31, 2024
(Unaudited)
THE “UNAUDITED MUTUAL FUNDS HOLDINGS” LIST (“the
List”) IS TO BE USED FOR REPORTING PURPOSES ONLY. IT IS
NOT TO BE REPRODUCED FOR USE AS ADVERTISING OR
SALES LITERATURE WITH THE GENERAL PUBLIC. The list is
submitted for the general information of the shareholders of the Fund.
It is not authorized for distribution to prospective investors in the Fund
unless preceded or accompanied by a prospectus. The list has been
created from the books and records of the Fund. Holdings are
available 60 days after the fund’s fiscal quarter, using a trade date
accounting convention, by contacting the appropriate service center.
The list is subject to change without notice. The list is for
informational purposes only and is not intended as an offer or
solicitation with respect to the purchase or sale of any security.
JPMorgan Asset Management is the marketing name for the asset
management business of J.P. Morgan Chase & Co.
J.P. Morgan Distribution Services, Inc., member FINRA.
© J.P. Morgan Chase & Co., 2024.

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — 98.9%
Aerospace & Defense — 3.5%
General Dynamics Corp.
277
78,397
Northrop Grumman Corp.
118
56,396
RTX Corp.
663
64,672
 
 
199,465
Air Freight & Logistics — 1.6%
United Parcel Service, Inc., Class B
640
95,098
Banks — 8.0%
Bank of America Corp.
3,276
124,211
M&T Bank Corp.
367
53,398
PNC Financial Services Group, Inc. (The)
395
63,789
US Bancorp
1,445
64,609
Wells Fargo & Co.
2,655
153,905
 
 
459,912
Beverages — 0.7%
PepsiCo, Inc.
239
41,793
Biotechnology — 3.7%
AbbVie, Inc.
534
97,184
Biogen, Inc.*
67
14,337
Regeneron Pharmaceuticals, Inc.*
47
45,682
Vertex Pharmaceuticals, Inc.*
130
54,288
 
 
211,491
Building Products — 1.4%
Carrier Global Corp.
1,395
81,117
Capital Markets — 6.7%
BlackRock, Inc.
135
113,013
Charles Schwab Corp. (The)
1,353
97,850
Goldman Sachs Group, Inc. (The)
93
38,711
Morgan Stanley
1,115
104,989
S&P Global, Inc.
69
29,417
 
 
383,980
Chemicals — 3.3%
Air Products and Chemicals, Inc.
352
85,354
Axalta Coating Systems Ltd.*
3,138
107,909
 
 
193,263
Commercial Services & Supplies — 0.7%
Republic Services, Inc.
221
42,395
Construction Materials — 1.4%
Vulcan Materials Co.
303
82,762
Consumer Finance — 1.8%
American Express Co.
355
80,910
Capital One Financial Corp.
146
21,698
 
 
102,608

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Consumer Staples Distribution & Retail — 1.8%
Dollar General Corp.
215
33,563
Walmart, Inc.
1,160
69,791
 
 
103,354
Containers & Packaging — 0.4%
Ball Corp.
383
25,775
Electric Utilities — 2.0%
Entergy Corp.
167
17,666
NextEra Energy, Inc.
953
60,898
Xcel Energy, Inc.
634
34,103
 
 
112,667
Electrical Equipment — 1.7%
Eaton Corp. plc
313
97,716
Entertainment — 0.6%
Walt Disney Co. (The)
286
34,998
Financial Services — 3.0%
Berkshire Hathaway, Inc., Class B*
311
130,576
Fiserv, Inc.*
270
43,155
 
 
173,731
Food Products — 0.8%
Mondelez International, Inc., Class A
621
43,449
Ground Transportation — 2.8%
CSX Corp.
2,959
109,703
Union Pacific Corp.
221
54,372
 
 
164,075
Health Care Equipment & Supplies — 3.5%
Becton Dickinson & Co.
163
40,356
Boston Scientific Corp.*
921
63,074
Medtronic plc
649
56,536
Zimmer Biomet Holdings, Inc.
308
40,649
 
 
200,615
Health Care Providers & Services — 4.3%
Cigna Group (The)
198
71,739
Humana, Inc.
103
35,681
UnitedHealth Group, Inc.
218
108,020
Universal Health Services, Inc., Class B
181
33,044
 
 
248,484
Health Care REITs — 0.4%
Ventas, Inc.
476
20,712
Hotel & Resort REITs — 0.5%
Host Hotels & Resorts, Inc.
1,514
31,303

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Hotels, Restaurants & Leisure — 1.5%
Booking Holdings, Inc.
8
27,206
McDonald's Corp.
201
56,805
 
 
84,011
Household Products — 1.3%
Procter & Gamble Co. (The)
448
72,666
Insurance — 4.1%
Chubb Ltd.
251
64,950
Hartford Financial Services Group, Inc. (The)
661
68,156
Marsh & McLennan Cos., Inc.
137
28,225
MetLife, Inc.
671
49,751
Prudential Financial, Inc.
235
27,593
 
 
238,675
Interactive Media & Services — 2.2%
Alphabet, Inc., Class C*
385
58,673
Meta Platforms, Inc., Class A
144
69,704
 
 
128,377
IT Services — 0.6%
International Business Machines Corp.
183
34,873
Machinery — 2.6%
Dover Corp.
512
90,692
Parker-Hannifin Corp.
107
59,446
 
 
150,138
Media — 1.4%
Comcast Corp., Class A
1,899
82,333
Multi-Utilities — 1.8%
CMS Energy Corp.
875
52,796
Public Service Enterprise Group, Inc.
801
53,480
 
 
106,276
Oil, Gas & Consumable Fuels — 8.3%
Chevron Corp.
786
124,034
ConocoPhillips
1,214
154,447
EOG Resources, Inc.
668
85,447
Exxon Mobil Corp.
1,010
117,355
 
 
481,283
Pharmaceuticals — 4.3%
Bristol-Myers Squibb Co.
1,539
83,466
Eli Lilly & Co.
44
34,404
Johnson & Johnson
523
82,763
Merck & Co., Inc.
178
23,425
Pfizer, Inc.
873
24,236
 
 
248,294
Residential REITs — 0.3%
AvalonBay Communities, Inc.
94
17,424

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Semiconductors & Semiconductor Equipment — 6.1%
Advanced Micro Devices, Inc.*
273
49,179
Analog Devices, Inc.
491
97,166
NXP Semiconductors NV (China)
364
90,072
Teradyne, Inc.(a)
305
34,424
Texas Instruments, Inc.
458
79,852
 
 
350,693
Software — 1.6%
Microsoft Corp.
216
91,052
Specialty Retail — 5.7%
AutoZone, Inc.*
20
63,184
Home Depot, Inc. (The)
178
68,181
Lowe's Cos., Inc.
331
84,473
O'Reilly Automotive, Inc.*
31
34,647
TJX Cos., Inc. (The)
793
80,448
 
 
330,933
Textiles, Apparel & Luxury Goods — 0.6%
NIKE, Inc., Class B
375
35,280
Tobacco — 1.4%
Philip Morris International, Inc.
863
79,082
Wireless Telecommunication Services — 0.5%
T-Mobile US, Inc.
178
29,108
Total Common Stocks
(Cost $4,388,515)
 
5,711,261
Short-Term Investments — 1.2%
Investment Companies — 0.9%
JPMorgan Prime Money Market Fund Class IM Shares, 5.43%(b) (c)
(Cost $53,132)
53,121
53,142
Investment of Cash Collateral from Securities Loaned — 0.3%
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 5.48%(b) (c)
10,994
10,994
JPMorgan U.S. Government Money Market Fund Class IM Shares, 5.25%(b) (c)
2,688
2,688
Total Investment of Cash Collateral from Securities Loaned
(Cost $13,686)
 
13,682
Total Short-Term Investments
(Cost $66,818)
 
66,824
Total Investments — 100.1%
(Cost $4,455,333)
 
5,778,085
Liabilities in Excess of Other Assets — (0.1)%
 
(3,859
)
NET ASSETS — 100.0%
 
5,774,226

Percentages indicated are based on net assets.

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
Abbreviations
 
REIT
Real Estate Investment Trust
*
Non-income producing security.
(a)
The security or a portion of this security is on loan at March 31, 2024. The total value of securities on loan at March 31, 2024 is $13,546.
(b)
Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment
Management Inc.
(c)
The rate shown is the current yield as of March 31, 2024.

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
(Dollar values in thousands)
A. Valuation of Investments Investments are valued in accordance with U.S. generally accepted accounting principles (“GAAP”) and the Fund's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the “Board”), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the Investment Company Act of 1940, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Funds on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of investments held in the Funds. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values (“NAV”) of the Fund are calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Fund's investments are summarized into the three broad levels listed below.
Level 1 Unadjusted inputs using quoted prices in active markets for identical investments.
Level 2 Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
Level 3 Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Fund's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments (“SOI”):
 
 
 
 
 
 
Level 1
Quoted prices
Level 2
Other significant
observable inputs
Level 3
Significant
unobservable inputs
Total
Total Investments in Securities(a)
$5,778,085
$
$
$5,778,085

 
(a)
Please refer to the SOI for specifics of portfolio holdings.
B. Investment Transactions with Affiliates The Fund invested in Underlying Funds advised by the Adviser. An issuer which is under common control with the Fund may be considered an affiliate. The Fund assumes the issuers listed in the table below to be affiliated issuers.

JPMorgan U.S. Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)
(Dollar values in thousands)
The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
 
For the period ended March 31, 2024
Security Description
Value at
June 30,
2023
Purchases at
Cost
Proceeds from
Sales
Net Realized
Gain (Loss)
Change in
Unrealized
Appreciation/
(Depreciation)
Value at
March 31,
2024
Shares at
March 31,
2024
Dividend
Income
Capital Gain
Distributions
JPMorgan Prime Money Market Fund Class IM Shares,
5.43% (a) (b)
$173,633
$863,234
$983,777
$48
$4
$53,142
53,121
$4,938
$
JPMorgan Securities Lending Money Market Fund
Agency SL Class Shares, 5.48% (a) (b)
40,000
29,000
(2
)
(4
)
10,994
10,994
200
JPMorgan U.S. Government Money Market Fund
Class IM Shares, 5.25% (a) (b)
13,244
10,556
2,688
2,688
27
Total
$173,633
$916,478
$1,023,333
$46
$
$66,824
 
$5,165
$

 
(a)
Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan
Investment Management Inc.
(b)
The rate shown is the current yield as of March 31, 2024.